Global Approaches for Collaboration and Networking

Emmeline Edwards is director of the Division of Extramural Research of the National Center for Complementary and Integrative Health (NCCIH). In that capacity, she is responsible for development of scientific programs or areas of science that fulfill NCCIH’s mission as well as planning, implementation, and policy. NCCIH is one of 27 components of the National Institutes of Health (NIH), with a mission to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care. Edwards earned her PhD in neurochemistry from Fordham University, did postdoctoral research in behavioral pharmacology and neuroscience at the State University of New York, and was a tenured associate professor in the department of pharmacology at the University of Maryland. Her research there focused on the neural mechanisms of complex behaviors and characterization of a genetic model of affective disorders. She also served as chair of the Graduate Studies and Research Committee and a member of the Dean’s Executive Council at the University of Maryland. Currently, Edwards is also chair of Women in World Neuroscience (WWN), an independent mentoring and networking organization with the primary mission of identifying, promoting, and implementing mentoring and networking opportunities for women neuroscientists across the world.

Martha I. Dávila-García is an associate professor of pharmacology at the Howard University College of Medicine. She is a member of the executive committee of the World Women in Neurosciences Group. She is on the board of directors of the Society for Advancement of Chicanos/Hispanics and Native Americans in Science, the largest multidisciplinary and multicultural organization in the country. Dávila-García’s main research interests lie in tobacco dependence and drugs of abuse effects on cardiovascular systems, nicotinic receptor pharmacology, and development of new nicotinic drugs. She received her undergraduate degree in biology from Slippery Rock University of Pennsylvania and her MS and PhD in biology/neurobiology from New York University. She completed postdoctoral training at the University of California, Irvine, and Georgetown University.

Orly Weinreb is the vice president of R&D at NeurOptic, Ltd., and a senior lecturer at Technion Israel Institute of Technology. Weinreb is a leading neuroscientist researcher and took major part in the research and development of the anti-Parkinson’s drug rasagiline (Azilect®). She earned her BS, MS, and PhD at Technion Israel Institute of Technology.

Pamela Butler is an associate professor of psychiatry at New York University School of Medicine and a research scientist at the Nathan Kline Institute for Psychiatric Research. She received her PhD in psychology from the City University of New York and did postdoctoral fellowships at Duke and Columbia universities. Her research centers on understanding deficits in perceptual and social function in schizophrenia. She currently has NIH grants to study perceptual cognitive remediation in schizophrenia and social reward learning in schizophrenia. She also teaches science writing at New York University.

Jean King an active neuroscientist and Peterson Family Dean of Arts and Sciences at Worcester Polytechnic Institute. Previously she was vice provost of biomedical research and a professor of psychiatry, radiology, and neurology at the University of Massachusetts Medical School. King’s current research interests include the use of novel multimodal neuroimaging techniques to explore the impact of stressors and addiction on neural networks, as well as neural mechanisms underlying comorbidity in disorders such as attention deficit hyperactivity disorder and traumatic brain injury. She received her doctorate in neurophysiology from New York University and completed postdoctoral training in translational neuroscience at Emory University.